David A. Siegel Procept Bio Robotics Corp Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 115,500 shares of PRCT stock, worth $5.56 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
115,500
Previous 90,000
28.33%
Holding current value
$5.56 Million
Previous $7.25 Million
7.13%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
300Shares Held
43.2MCall Options Held
286KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$247 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$168 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$103 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$68.1 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$57.1 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.15B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...